Brief Title
Cell-free Tumor DNA in Head and Neck Cancer Patients
Official Title
Cell-free Tumor DNAand HPV-DNA in Blood Samples From Newly Diagnosed Patients With Head and Neck Cancer
Brief Summary
This study investigates if head and neck squamous cell carcinoma can be tracked with cell-free tumor DNA, RNA or HPV-DNA, in blood samples from patients referred with suspicion of cancer, and if it can be used in detecting recurrence in patients already diagnosed and treated for head and neck squamous cell carcinoma.
Study Type
Interventional
Primary Outcome
Percentage of head and neck cancer detected with a blood sample
Condition
Head and Neck Cancer
Intervention
Liquid biopsy
Study Arms / Comparison Groups
Cell-free tumor DNA
Description: The aim is to differentiate between patients with head and neck cancer from those without based on a blood sample.
Publications
* Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.
Recruitment Information
Recruitment Status
Diagnostic Test
Estimated Enrollment
500
Start Date
February 1, 2017
Completion Date
February 1, 2025
Primary Completion Date
February 1, 2025
Eligibility Criteria
Inclusion Criteria: - Patients 18 years old or older - Suspicion of head and neck cancer Exclusion Criteria: - Diagnosed with cancer within the last 3 years ( apart from basal cell carcinoma) - Diagnosed with an inflammatory or haematological disease after the age of 18 - Received chemotherapy or immunosuppressive treatment within the last 3 years - Underwent a FNA ( fine-needle aspiration biopsy) or a biopsy from the head and neck region within 1 week.
Gender
All
Ages
18 Years - N/A
Accepts Healthy Volunteers
No
Contacts
Christian Von Buchwald, MD, DMSc, 004526276374, [email protected]
Location Countries
Denmark
Location Countries
Denmark
Administrative Informations
NCT ID
NCT03942380
Organization ID
1301261
Responsible Party
Sponsor-Investigator
Study Sponsor
Christian von Buchwald
Collaborators
Copenhagen University Hospital, Denmark
Study Sponsor
Christian Von Buchwald, MD, DMSc, Principal Investigator, Department of Otorhinolaryngology, Head and Neck Surgery and Audiology
Verification Date
September 2021